Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025CureusOpen Access

Gestational Trophoblastic Disease in Bahrain: Prevalence, Risk Factors, and Outcomes

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAbrar M AlnasheetNMNaeema Mahmood

Discussion

Loading...

Member takes

Overview

Retrospective cohort analysis reveals prevalence and risk factors of gestational trophoblastic disease in Bahrain, highlighting potential complications and outcomes.

Key Points

  • Gestational trophoblastic disease affects women in Bahrain, with a prevalence influenced by age and consanguinity.
  • The study found that 71.4% of cases were complete hydatidiform moles, while 6.4% progressed to gestational trophoblastic neoplasia.
  • Mean normalization time for β-hCG was 54.6 days for complete moles, highlighting notable differences in clinical outcomes.
  • Findings may inform future initiatives aimed at improving early detection and management of gestational trophoblastic disease.

Cite This Study

Alnasheet et al. (2025) studied this question.

synapsesocial.com/papers/68c23fc3b210217d64797495https://doi.org/10.7759/cureus.89233
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Gestational Trophoblastic Neoplasia: Evaluation of Prognostic Factors, Mode of Treatment and Responses2025
  2. 2Analysis of 401 Cases of Gestational Trophoblastic Disease (GTD) at Bangabandhu Sheikh Mujib Medical University (BSMMU)2025
  3. 3Gestational Trophoblastic Disease: Diagnostic and Therapeutic Updates in Light of Recent Evidence: A Literature Review2025
  4. 4Gestational Trophoblastic Neoplasia: A Retrospective Study from a Tertiary Cancer Care Centre in Eastern India2025
  5. 5B-338 Gestational Trophoblastic Disease (Hydatidiform Mole) with B-hCG Levels. Study of 2019 to 20242025